+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Pertussis- Pipeline Insight, 2025 - Product Thumbnail Image

Pertussis- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Invasive Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Invasive Aspergillosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Malignant Ascites - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Ascites - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Batten Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Batten Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Ghrelin Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Ghrelin Receptor Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Glucocorticoid Receptor (GR) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucocorticoid Receptor (GR) Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Lipoxygenase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Lipoxygenase Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Alpha-Synuclein (alphaSyn Or SNCA) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-Synuclein (alphaSyn Or SNCA) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Toll-Like Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Toll-Like Receptor Agonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin 13 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 13 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin 4 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 4 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Allergic Fungal Rhinosinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Allergic Fungal Rhinosinusitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Recessive Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Recessive Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lebers Hereditary Optic Neuropathy (lhon) - Pipeline Insight, 2025 - Product Thumbnail Image

Lebers Hereditary Optic Neuropathy (lhon) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Restless Leg Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Restless Leg Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lactose Intolerance - Pipeline Insight, 2025 - Product Thumbnail Image

Lactose Intolerance - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypothalamic Obesity (HO) - Pipeline Insight, 2025 - Product Thumbnail Image

Hypothalamic Obesity (HO) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Primary Progressive Aphasia - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Progressive Aphasia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more